Treatment - Antiviral Drugs
Note: On June 22, 2016, CDC’s Advisory Committee on Immunization Practices (ACIP) recommended a change to U.S. influenza vaccination policy for 2016-2017. The ACIP recommendation must be reviewed and approved by CDC’s Director, and the final recommendations will be published in a CDC Morbidity and Mortality Weekly Report (MMWR), in late summer or early fall. The content of this website will be reviewed and updated prior to the 2016-2017 influenza season.
- What You Should Know About Flu Antiviral Drugs
- Antiviral Drug Supply
- Treating Influenza (Flu)[927 KB, 2 pages, 8 ½" x 11"]
Information for people with asthma, diabetes and chronic cardiovascular disease
- Questions & Answers: Opening and Mixing Tamiflu® Capsules with Liquids if Child Cannot Swallow Capsules
- Questions & Answers: Influenza Antiviral Drug Resistance
- Influenza Round Table: Antiviral Drugs
Dr. Joe Bresee explains the nature of antiviral drugs and how they are used for seasonal flu.
- Why CDC Recommends Influenza Antiviral Drugs
- Antiviral Drugs
- Additional Resources on Influenza Antiviral Drugs
More information about oseltamivir, zanamivir, peramivir, amantadine, and rimantadine.
Other Important Information For People Sick With Flu
- Page last reviewed: July 22, 2016
- Page last updated: July 22, 2016
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs